Currently out of the existing stock ratings of Steve Byrne, 34 are a SELL (19.65%), 81 are a BUY (46.82%), 58 are a HOLD (33.53%).

Steve Byrne

Work Performance Price Targets & Ratings Chart

Analyst Steve Byrne, currently employed at BAML, carries an average stock price target met ratio of 69.61% that have a potential upside of 20.22% achieved within 233 days.

Steve Byrne’s has documented 514 price targets and ratings displayed on 32 stocks. The coverage is on Basic Materials, Consumer Defensive, Healthcare sectors.

Most recent stock forecast was given on CTVA, Corteva at 20-Nov-2024.

Wall Street Analyst Steve Byrne

Analyst best performing recommendations are on PCRX (PACIRA PHARMACEUTICALS).
The best stock recommendation documented was for GPRE (GREEN PLAINS RENEWABLE ENERGY) at 10/24/2022. The price target of $35 was fulfilled within 17 days with a profit of $7.74 (28.39%) receiving and performance score of 16.7.

Average potential price target upside

of $71.85 (23.67%) on LIN (LINDE PLC ORDINARY SHARES).
of $60.94 (33.19%) on ALB (ALBEMARLE CORP).
of $42.38 (18.26%) on APD (AIR PRODUCTS AND CHEMICALS).

ALB Albemarle Corp CE Celanese CF CF Industries Holdings CTVA Corteva DD Dupont De Nemours FMC FMC HUN Huntsman LIN Linde plc Ordinary Shares LTHM Livent Corp LYB LyondellBasell Industries NV MOS The Mosaic Company NTR Nutrien Ltd OLN Olin RPM RPM International SHW Sherwin-Williams Co WLK Westlake Chemical APD Air Products and Chemicals BG Bunge ECL Ecolab PPG PPG Industries UNVR Univar VNTR Venator Materials PLC ADM Archer-Daniels-Midland Company AXTA Axalta Coating Systems Ltd GPRE Green Plains Renewable Energy ORGN Origin Materials DOW Dow MNKD MannKind Corp PCRX Pacira Pharmaceuticals SRPT Sarepta Therapeutics EMN Eastman Chemical Company CC Chemours Co

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Ben Kallo (BAIRD)